» Articles » PMID: 1335166

Retinoids Selective for Retinoid X Receptor Response Pathways

Overview
Journal Science
Specialty Science
Date 1992 Dec 18
PMID 1335166
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoids have a broad spectrum of biological activities and are useful therapeutic agents. Their physiological activities are mediated by two types of receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). RARs, as well as several related receptors, require heterodimerization with RXRs for effective DNA binding and function. However, in the presence of 9-cis-retinoic acid, a ligand for both RARs and RXRs, RXRs can also form homodimers. A series of retinoids is reported that selectively activates RXR homodimers but does not affect RAR-RXR heterodimers and thus demonstrates that both retinoid response pathways can be independently activated.

Citing Articles

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential.

Xu R, Zhang L, Pan H, Zhang Y Front Pharmacol. 2024; 15:1464655.

PMID: 39478961 PMC: 11521896. DOI: 10.3389/fphar.2024.1464655.


Association of Plasma Vitamins and Carotenoids, DNA Methylation of LCAT, and Risk of Age-Related Macular Degeneration.

Li Z, Li Y, Hou Y, Fan Y, Jiang H, Li B Nutrients. 2023; 15(13).

PMID: 37447314 PMC: 10347047. DOI: 10.3390/nu15132985.


Exploring the interactions of antihistamine with retinoic acid receptor beta (RARB) by molecular dynamics simulations and genome-wide meta-analysis.

Kim M, Kulkarni V, Goode M, Sivesind T J Mol Graph Model. 2023; 124:108539.

PMID: 37331258 PMC: 10529808. DOI: 10.1016/j.jmgm.2023.108539.


Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction.

Zhao J, Yuan X, Luo R, Wang L, Gu W, Yamane D Front Immunol. 2023; 14:1107239.

PMID: 37063830 PMC: 10102619. DOI: 10.3389/fimmu.2023.1107239.


An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.

Jurutka P, Di Martino O, Reshi S, Mallick S, Sausedo M, Moen G Int J Mol Sci. 2022; 23(24).

PMID: 36555852 PMC: 9782500. DOI: 10.3390/ijms232416213.